Explore All 400 Growth Capital Life Science Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | April 16, 2024 |
| Target | Curida |
| Sector | Life Science |
| Investor(s) | Signet Healthcare Partners |
| Deal Type | Growth Capital |
| Advisor(s) | DNB Markets (Financial) Simonsen Vogt Wiig (Legal) |
FILTER BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1998 |
| PE ASSETS | 600M USD |
| Size | Middle-Market |
| Type | Sector Focused |
Signet Healthcare Partners is a growth capital firm focused on the healthcare sector. Specific areas of interest include specialty pharmaceuticals, pharmaceutical services, medical devices, and diagnostics. Signet will consider opportunities throughout North America and Europe and looks to commit $10 to $50 million per transaction. Signet Healthcare Partners was established in 1998 and is headquartered in New York, New York.
| Deal Context for Investor | # |
|---|---|
| Overall | 16 of 17 |
| Sector: Life Science | 13 of 14 |
| Type: Growth Capital | 10 of 11 |
| Country: Norway | 1 of 1 |
| Year: 2024 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-06-13 |
RK Pharma
Pearl River, New York, United States RK Pharma is a fully integrated generic pharmaceutical company that develops complex API and injectable finished dosage products. RK Pharma was founded in 2018 and is based in Pearl River, New York. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-08-22 |
Paragonix Technologies
Waltham, Massachusetts, United States Paragonix Technologies is a developer, manufacturer, and service provider in the organ transplant industry, establishing a novel approach to organ preservation. Paragonix Technologies provides Advanced Organ Preservation (“AOP”) devices that safeguard donor organs during the journey between donor and recipient patients. Paragonix Technologies is based in Waltham, Massachusetts. |
Sell | - |
